JY
MTFB

Jeff Yass’s Motif Bio plc ADRs MTFB Stock Holding History

Jeff Yass’s Portfolio MTFB Stock Details MTFB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-39,657
Closed -$26K – 11197
2019
Q2 		$26K Buy
39,657
+26,740
+207% +$46.5K ﹤0.01% 9976
2019
Q1 		$24K Buy
+12,917
New +$73.6K ﹤0.01% 8576

Other funds holding MTFB

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's MTFB Position: Q3 2019 in Review

Jeff Yass sold out of Motif Bio plc ADRs (MTFB) in Q3 2019, closing a stake of 39,657 shares — an estimated $26K sold.

Jeff Yass first reported a position in MTFB in Q1 2019 and held it in 2 quarters. The position peaked at $26K in Q2 2019. 6 funds tracked by Wall St. Rank hold MTFB as of Q3 2019.

  • Jeff Yass reported no remaining Motif Bio plc ADRs position as of Q3 2019 after selling out during the quarter.
  • Jeff Yass sold 39,657 Motif Bio plc ADRs shares in Q3 2019, an estimated $26K.
  • Jeff Yass first reported a position in Motif Bio plc ADRs in Q1 2019 and held it in 2 quarters.
  • Jeff Yass's Motif Bio plc ADRs position peaked at $26K in Q2 2019.
  • 6 funds tracked by Wall St. Rank held Motif Bio plc ADRs as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.